echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Korean Ginseng Research Institute announces that red ginseng may have the adjuvant effect of new crown vaccine

    Korean Ginseng Research Institute announces that red ginseng may have the adjuvant effect of new crown vaccine

    • Last Update: 2021-11-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Seoul, South Korea, October 21, 2021/PRNewswire/ - The Korean Ginseng Research Institute recently released a report on "Red Ginseng Vaccine Adjuvant Effect"[1] and "Respiratory Injury Prevention Effect" Summary of research results


    Korean Ginseng Research Institute announces that red ginseng may have the adjuvant effect of new crown vaccine

    The research results outlined in this review show that red ginseng improves the effectiveness of the vaccine.


    In the paper "Protective Effect of Korean Red Ginseng Extract on the Infections by H1N1 and H3N2 Influenza Viruses in Mice" published in the international academic journal "Journal of Medicinal Food" in 2021, it is mentioned that compared with mice that were only vaccinated, vaccinated The survival rate of mice receiving the vaccine and taking red ginseng concentrate has improved


    In the paper "Korean Red Ginseng enhances pneumococcal Δ pep27 vaccine efficacy by inhibiting reactive oxygen species production" published in the Journal of Ginseng Research in 2019, it was mentioned that mice infected with pneumococcal were injected with the vaccine (Δ pep27) at the same time.


    According to the Korean Ginseng Research Institute, these findings prove the vaccine adjuvant effect of red ginseng and the preventive effect of respiratory damage


    In South Korea, red ginseng has been officially recognized as a healthy functional food by the Ministry of Food and Drug Safety, a national agency that regulates drug and food safety


    The representative red ginseng company in South Korea is the Korean Ginseng Corporation, whose famous CheongKwanJang brand accounts for about 70% of the entire red ginseng market


    Last year, the Korean Ginseng Corporation and the International Vaccine Institute (IVI) signed a memorandum of understanding, and the two sides cooperated in the development of immune enhancers and the ingredients required for the use of red ginseng for new crown vaccine research


    Immune enhancers are substances that enhance the immune response caused by antigens


    Kim Jae-soo, president of the Korean Ginseng Corporation, said: “After the spread of the new crown virus, the number of people looking for red ginseng to improve immunity and manage health has increased significantly in South Korea


    https://youtu.


    [1].


    KGC (Korea Ginseng Corp.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.